Acute inflammation in response to hernia meshes - A retrospective Analysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034850

Enrollment

500

Registered

2024-08-13

Start date

2024-05-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K42 K43 K45 K46

Interventions

Group 1: Sublayherniotomie using ULTRAPRO(R)-mesh Group 2: Sublayherniotomie using ProGrip TM-mesh

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Missing follow-up and patient data

Exclusion criteria

Exclusion criteria: Other type of mesh for sublay herniotomy used

Design outcomes

Primary

Measure	Time frame
Serum C-reaktive protein as marker for systemic inflammation at postoperative day 2/3	—

Secondary

Measure	Time frame
- Serum C-reactive protein as a marker of systemic inflammation on subsequent postoperative days - Perioperative white blood cell count - Characteristics of patients, surgeries, and hernias - Postoperative complications, stratified by Clavien-Dindo classification - Postoperative complications, summarized by the Comprehensive Complication Index - Rates of postoperative seromas, wound infections, mesh infections, and re-operations - Hernia recurrence rates in long-term follow-up (3 years)	—

Measure

Time frame

- Serum C-reactive protein as a marker of systemic inflammation on subsequent postoperative days - Perioperative white blood cell count - Characteristics of patients, surgeries, and hernias - Postoperative complications, stratified by Clavien-Dindo classification - Postoperative complications, summarized by the Comprehensive Complication Index - Rates of postoperative seromas, wound infections, mesh infections, and re-operations - Hernia recurrence rates in long-term follow-up (3 years)

—

Countries

Germany

Contacts

Public ContactMartin Reichert

Department of General, Visceral, Thoracic and Transplant Surgery, University Hospital of Giessen

martin.reichert@chiru.med.uni-giessen.de+4964198544701

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026